Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04251065 Background | Sep 2020 → Dec 2021 | T-cell non-Hodgkin lymphoma | Fondazione Italiana Linfomi - ETS | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | “Granulocyte-colony stimulating factor (G-CSF) from day 3 to 6, and from day 10 to 13” NCT04251065 ↗ |